High Shear Processing Leader Applies For Microfluidics Reaction Technology™ (MRT) Patent in Japan
Newton, MA (PRWEB) April 21, 2010 -- Microfluidics International Corporation (OTCBB: MFLU) today announced that, along with its exclusive Japanese distributor, POWREX Corporation, it has introduced Microfluidics Reaction Technology (MRT) to Japan as the world's only viable large-scale, bottom-up technology for nanoparticle creation. MRT is a revolutionary platform which enables continuous pharmaceutical manufacturing via crystallization and multi-phase chemical reactions.
POWREX is one of the largest providers of technology to the pharmaceutical industry in Japan. The announcement was made at the POWREX Symposium in Osaka this week and at a press conference to be held on April 21, 8:30 AM, at INTERPHEX 2010 in Manhattan.
"Japanese companies and researchers are visionary innovators, and we are pleased to offer them the latest nanomaterials processing methods available to achieve new goals," said Takeshi Takashima, President of POWREX. "Our strong partnership with Microfluidics enables us to bring this innovative and important technology to potential customers in Japan."
The technology has immediate value in pharmaceutical industry, such as creating more effective and targeted drugs. Japan is the second-largest single-country pharmaceutical market in the world.
"MRT allows companies to improve bioavailability, target delivery and encapsulate actives more efficiently than any top-down process or traditional crystallization method," said Thomai "Mimi" Panagiotou, PhD., Microfluidics Chief Technology Officer. "Importantly, its innovative capabilities for continuous crystallization and chemical reactions have the potential to transform the manufacture of drugs and chemicals by significantly streamlining the steps, timing and cost of consistent, continuous large-scale commercial production."
Microfluidics Japanese Patent Application
Microfluidics has applied for a Japanese patent on MRT entitled "Apparatus and Methods for Nanoparticle Generation and Process Intensification of Transport and Reaction Systems." This is the first time that the Company has filed for this type of charter outside of the United States.
"Because we have such confidence in our valued partner, POWREX, we are filing for a patent and are eager to introduce this revolutionary platform technology to Japan," said Michael C. Ferrara, President and CEO of Microfluidics. "MRT enables pharmaceutical companies interested in continuous manufacturing to break new ground in crystallization and nanotechnology application development. POWREX engineers have been well trained to understand how to make the most of the results through a combination of a unique processor and expert process development skills. Their collective experience and dedication in the pharmaceutical, biotechnology and energy industries will align their customers for success."
To learn more about MRT attend the Microfluidics press conference, visit the company's INTERPHEX 2010 (April 20-22, 2010, NYC) booth #2214 or contact Kris Sarajian at ksarajian(at)mfics(dot)com or (+1) 617.969.5452 x233.
ABOUT POWREX CORPORATION
Established in 1950 as Fuji Kikai Kohgyo Co, Ltd., and based in Hyogo, POWREX has grown over the past half-century to become one of the largest processing technologies companies in Japan. POWREX partners with its customers to deliver value-added original powder processing solutions including hardware, software and engineering services.
Microfluidics (OTCBB: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.
By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit www.microfluidicscorp.com.
Microfluidics International Corporation
617-9695452 ext. 233
Rudolph Communications, LLC
# # #
Read the full story at http://www.prweb.com/releases/POWREXMRT/MicrofluidicsJapan/prweb3895924.htm.
Copyright©2010 Vocus, Inc.
All rights reserved